| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1161/CIRCULATIONAHA.107.696732 |
| P698 | PubMed publication ID | 19451364 |
| P2093 | author name string | Matthew J Price | |
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2625-2632 | |
| P577 | publication date | 2009-05-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Bedside evaluation of thienopyridine antiplatelet therapy | |
| P478 | volume | 119 |
| Q36081188 | A pharmacodynamic study of the optimal P2Y12 inhibitor regimen for East Asian patients with acute coronary syndrome |
| Q34990246 | A randomised trial of the pharmacodynamic and pharmacokinetic effects of ticagrelor compared with clopidogrel in Hispanic patients with stable coronary artery disease |
| Q57764209 | ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome |
| Q38037121 | Advances in the monitoring of anti-P2Y12 therapy. |
| Q36087455 | An Assay of Measuring Platelet Reactivity Using Monoclonal Antibody against Activated Platelet Glycoprotein IIb/IIIa in Patients Taking Clopidogrel |
| Q35278165 | Anti-platelet therapy: ADP receptor antagonists |
| Q37174455 | Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial |
| Q57549243 | Case report: use of thienopyridines in a patient with acquired idiopathic thrombotic thrombocytopenic purpura |
| Q92481803 | Clopidogrel non-responsiveness in patients undergoing percutaneous coronary intervention using the VerifyNow test: frequency and predictors |
| Q35658513 | Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet Therapy |
| Q30528515 | Development of a perfusion chamber assay to study in real time the kinetics of thrombosis and the antithrombotic characteristics of antiplatelet drugs |
| Q51747597 | Effects of clopidogrel therapy on whole blood platelet aggregation, the Plateletworks® assay and coagulation parameters in cats with asymptomatic hypertrophic cardiomyopathy: a pilot study. |
| Q39322667 | Effects of testosterone and 17β-oestradiol on expression of the G protein-coupled receptor P2Y12 in megakaryocytic DAMI cells. |
| Q54546944 | Evaluation of the role of the new INNOVANCE PFA P2Y test cartridge in detection of clopidogrel resistance. |
| Q37709405 | Factors associated with clopidogrel nonresponsiveness |
| Q37841568 | Functional testing methods for the antiplatelet effect of P2Y12 receptor antagonists |
| Q37697779 | Genetic causes of clopidogrel nonresponsiveness: which ones really count? |
| Q41826841 | Genotype- and Phenotype-Directed Personalization of Antiplatelet Treatment in Patients with Non-ST Elevation Acute Coronary Syndromes Undergoing Coronary Stenting |
| Q37291972 | Head to Head Comparison of Two Point-of-care Platelet Function Tests Used for Assessment of On-clopidogrel Platelet Reactivity in Chinese Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention |
| Q45823009 | Hematocrit alters VerifyNow P2Y12 assay results independently of intrinsic platelet reactivity and clopidogrel responsiveness |
| Q30450312 | High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study |
| Q34536091 | Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism |
| Q46319910 | Identification of PEAR1 SNPs and their influences on the variation in prasugrel pharmacodynamics |
| Q34025783 | Immune cell regulation by autocrine purinergic signalling |
| Q94526212 | Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention |
| Q33990428 | Implementing genotype-guided antithrombotic therapy |
| Q51498312 | Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial. |
| Q42723622 | Interaction between clopidogrel and proton-pump inhibitors |
| Q89396705 | Lower on-treatment platelet reactivity during everolimus-eluting stent implantation contributes to the resolution of post-procedural intra-stent thrombus: serial OCT observation in the PRASFIT-Elective study |
| Q41926971 | Multiple and Contemporary Coronary Thrombosis inspite of Low Platelet Function Response |
| Q34108764 | Mutational analysis clopidogrel resistance and platelet function in patients scheduled for coronary artery bypass grafting |
| Q38366950 | Novel anti-platelet agents in acute coronary syndrome: mechanisms of action and opportunities to tailor therapy. |
| Q84009913 | Optimizing of thienopyridine therapy by multiple electrode platelet aggregometry in clopidogrel low responders undergoing PCI |
| Q38068348 | Platelet function monitoring and clopidogrel |
| Q36822610 | Platelet function testing to predict hyporesponsiveness to clopidogrel in patients with chest pain seen in the emergency department |
| Q93024156 | Platelet inhibition to target reperfusion injury trial: Rationale and study design |
| Q86690727 | Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study |
| Q44587286 | Platelet reactivity after coronary stenting |
| Q36244001 | Platelet reactivity in human immunodeficiency virus infected patients on dual antiplatelet therapy for an acute coronary syndrome: the EVERE2ST-HIV study |
| Q52969586 | Point-of-care platelet function testing predicts bleeding in patients exposed to clopidogrel undergoing coronary artery bypass grafting: Verify pre-op TIMI 45--a pilot study. |
| Q90623028 | Safety and Efficacy of Prasugrel in Elderly/Low Body Weight Japanese Patients with Ischemic Stroke: Randomized PRASTRO-II |
| Q37697014 | State of the art of new P2Y12 antagonists. |
| Q53084647 | Ticagrelor versus prasugrel in patients with high on-clopidogrel treatment platelet reactivity after PCI: The ISAR-ADAPT-PF study. |
| Q48236843 | Use of Aspirin and P2Y12 Response Assays in Detecting Reversal of Platelet Inhibition With Platelet Transfusion in Patients With Traumatic Brain Injury on Antiplatelet Therapy |
| Q48236832 | Utility of the Aspirin and P2Y12 Response Assays to Determine the Effect of Antiplatelet Agents on Platelet Reactivity in Traumatic Brain Injury. |
Search more.